3rd Apr 2008 12:27
Skyepharma PLC03 April 2008 For Immediate Release 3 April 2008 SkyePharma PLC ("the Company") The Company was informed on 2 April 2008 that as a result of transactions on 2April 2008 by the SkyePharma PLC Share Purchase Plan (an approved all employeeshare purchase plan) the Trustees of the Plan purchased an additional 11,520Ordinary Shares of the Company at a price of 12.5 pence per share. Following these transactions, the Trustees hold on behalf of the Plan, 203,916Ordinary Shares representing 0.025% of the share capital of the Company. Theclass of discretionary beneficiaries for whom the Trustees hold such sharesconsists of employees of the Company, including the following ExecutiveDirectors: Frank Condella and Peter Grant. As a result of these transactions, the following Executive Directors have thefollowing additional interests as a result of their personal participation inthe Plan:- Partnership Shares Matching Shares Total number of purchased on awarded on Partnership and 2 April 2008 at 2 April 2008 at Matching Shares 12.5p per share 12.5p per share held on 2 April 2008 Frank Condella 1,000 1,000 28,970Peter Grant 1,000 1,000 21,598 In accordance with the rules of the Plan these Directors have been awardedMatching Shares on the basis of one Matching Share (Ordinary Share) for eachPartnership Share (Ordinary Share). The beneficial ownership of the Matching Shares will pass to the Directors inthree years' time subject to continued employment and the retention of theunderlying Partnership Shares. The execution of the transaction noted above did not involve any of theCompany's Directors or any persons discharging managerial responsibility. This notification relates to transactions notified in accordance with Disclosureand Transparency Rule 3.1.4R(1)(a). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L